Orbimed Advisors LLC’s Merck & Co Inc Position
Does Orbimed Advisors LLC own Merck & Co Inc (MRK)? Yes — 663.4K shares worth $80M (+1.58% of its 13F portfolio) as of Q1 2026, down from 829.9K shares the prior filed quarter.
Position Value
$80M
Q1 2026
Shares
663.4K
% of Portfolio
+1.58%
Quarters Held
20
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 663.4K | $80M | +1.58% |
| Q4 2024 | 829.9K | $83M | +1.70% |
| Q3 2024 | 1.32M | $149M | +2.72% |
| Q2 2024 | 1.32M | $163M | +3.22% |
| Q1 2024 | 1.32M | $174M | +3.18% |
| Q4 2023 | 1.05M | $115M | +2.30% |
| Q3 2023 | 1.05M | $109M | +2.31% |
| Q4 2021 | 1.78M | $136M | +1.75% |
| Q3 2021 | 3.73M | $280M | +3.08% |
| Q2 2021 | 3.73M | $290M | +2.94% |
| Q1 2021 | 3.73M | $288M | +2.69% |
| Q4 2020 | 2.66M | $218M | +1.90% |
| Q3 2020 | 2.59M | $215M | +2.70% |
| Q2 2020 | 2.59M | $200M | +2.82% |
| Q1 2020 | 2.59M | $199M | +3.35% |
| Q4 2019 | 1.95M | $178M | +2.54% |
| Q3 2019 | 1.95M | $164M | +3.12% |
| Q2 2019 | 2.57M | $216M | +3.34% |
| Q1 2019 | 2.57M | $214M | +3.31% |
| Q4 2018 | 2.50M | $191M | +3.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of MRK.